2010Chinese Journal of General PracticeRequires access

The Study of Ozagrel in the Treatment of Early Cerebral Infarction

Deng Hong-qiong

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of Ozagrel in treatment of early cerebral infarction.Methods 176 cases of patients with cerebral infarction were randomly divided into treatment group( Ozagrel,114 patients) and control group(62 cases).Infusion Ozagrel 80 mg/times,2 times/d was adopted in treatment group.Control group:infusion Venoruton 0.4 g/times,1 times/d.Both were treated for weeks.Use of the Fourth national Cerebrovascular Disease Conference adopted a standard score for stroke in patients with neurological impairment for efficacy evaluation.Results The results of clinical assessment of neurological deficits of Ozagrel treatment group after two weeks had an advantage over the control group.No obvious side effects were found.Conclusion The treatment of acute cerebral infarction by Ozagrel was obvious,safe and reliable.

About this research paper

What this paper is about

Objective To observe the clinical effect of Ozagrel in treatment of early cerebral infarction.Methods 176 cases of patients with cerebral infarction were randomly divided into treatment group( Ozagrel,114 patients) and control group(62 cases).Infusion Ozagrel 80 mg/times,2 times/d was adopted in treatment group.Control group:infusion Venoruton 0.4 g/times,1 times/d.Both were treated for weeks.Use of the Fourth national Cerebrovascular Disease Conference adopted a standard score for stroke in patients with neurological impairment for efficacy evaluation.Results The results of clinical assessment of neurological deficits of Ozagrel treatment group after two weeks had an advantage over the control group.No obvious side effects were found.Conclusion The treatment of acute cerebral infarction by Ozagrel was obvious,safe and reliable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of Ozagrel in treatment of early cerebral infarction.Methods 176 cases of patients with cerebral infarction were randomly divided into treatment group( Ozagrel,114 patients) and control group(62 cases).Infusion Ozagrel 80 mg/times,2 times/d was adopted in treatment group.Control group:infusion Venoruton 0.4 g/times,1 times/d.Both were treated for weeks.Use of the Fourth national Cerebrovascular Disease Conference adopted a standard score for stroke in patients with neurological impairment for efficacy evaluation.Results The results of clinical assessment of neurological deficits of Ozagrel treatment group after two weeks had an advantage over the control group.No obvious side effects were found.Conclusion The treatment of acute cerebral infarction by Ozagrel was obvious,safe and reliable.

Key concepts: Medicine, Cerebral infarction, Anesthesia, Treatment and control groups, Clinical efficacy, Surgery, Internal medicine, Ischemia

Related papers

Back to paper searchBrowse research topicsOriginal source
The Study of Ozagrel in the Treatment of Early Cerebral Infarction — Research Paper | ScholarLens